AIM · AIM ImmunoTech Inc. · Documents

Aug 15

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $30K ▲ 30.4% Net loss $4.85M

Aug 15

Proxy statement DEFA14A

Proxy statement

Jul 18

Current report 8-K Events of Jul 14

Other events

Jun 21

Current report 8-K Events of Jun 16

Entered into a material agreement

Jun 17

Current report 8-K Events of Jun 13

Entered into a material agreement

May 13

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $33K ▲ 17.9% Net loss $3.82M

Apr 12

Current report 8-K Events of Apr 7

Entered into a material agreement, Regulation FD disclosure

Mar 31

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $135K ▼ 17.2% Net loss $19.13M

Mar 28

Current report 8-K

Regulation FD disclosure

Mar 16

Current report 8-K Events of Mar 11

Other events

Mar 7

Current report 8-K Events of Mar 2

Entered into a material agreement, Director or officer change, or executive pay

Mar 3

Current report 8-K Events of Mar 1

Entered into a material agreement, Director or officer change, or executive pay

Jan 27

Current report 8-K

Regulation FD disclosure

Jan 26

Current report 8-K

Regulation FD disclosure

Jan 24

Current report 8-K Events of Jan 19

Regulation FD disclosure

Jan 21

Registration statement S-3

Registration statement

Dec 9

Current report 8-K Events of Nov 29

Regulation FD disclosure, Other events

Nov 15

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $33K ▼ 8.3% Net loss $3.83M

Oct 7

Current report 8-K

Shareholder vote results

Oct 6

Current report 8-K Events of Oct 5

Regulation FD disclosure

Sep 30

Current report 8-K Events of Sep 27

Entered into a material agreement

Sep 21

Current report 8-K Events of Sep 20

Director or officer change, or executive pay

Sep 17

Current report 8-K

Regulation FD disclosure

Aug 17

Proxy statement DEF 14A

Proxy statement

Aug 17

Quarterly report 10-Q/A Ended Jun 30

Quarterly report for the period ended Jun 30, 2021

Aug 16

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $23K ▼ 42.5% Net loss $5.88M

Jul 14

Current report 8-K

Regulation FD disclosure, Other events

Jul 13

Current report 8-K Events of Jul 8

Entered into a material agreement

Jun 14

Current report 8-K Events of Mar 15

Other events

May 27

Current report 8-K Events of May 21

Entered into a material agreement, Regulation FD disclosure

May 18

Current report 8-K

Regulation FD disclosure

May 17

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $28K ▼ 37.8% Net loss $3.58M

May 6

Current report 8-K Events of May 5

Other events

May 3

Current report 8-K

Regulation FD disclosure

Apr 23

Current report 8-K Events of Apr 19

Completed an acquisition or sale of assets, Other events

Apr 19

Current report 8-K

Entered into a material agreement

Apr 9

Current report 8-K Events of Apr 5

Other events

Apr 7

Current report 8-K Events of Apr 5

Entered into a material agreement

Mar 31

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $163K ▲ 16.4% Net loss $14.4M

Mar 23

Current report 8-K

Regulation FD disclosure

Mar 22

Current report 8-K

Regulation FD disclosure

Mar 10

Current report 8-K

Regulation FD disclosure

Mar 8

Current report 8-K

Regulation FD disclosure

Feb 24

Current report 8-K Events of Feb 19

Other events

Feb 5

Current report 8-K Events of Feb 2

Other events

Jan 29

Current report 8-K Events of Jan 11

Entered into a material agreement

Jan 22

Current report 8-K Events of Jan 16

Change of auditor

Dec 23

Current report 8-K Events of Dec 22

Entered into a material agreement

Dec 11

Current report 8-K Events of Dec 8

Director or officer change, or executive pay

Nov 23

Current report 8-K Events of Nov 20

Regulation FD disclosure